Performance
Stock factor profile
JB Chemicals & Pharmaceuticals Ltd
JBCHEPHARM · Pharmaceuticals · Pharmaceuticals & Biotechnology
JB Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 5,095 full-time employees. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The firm is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). The company is involved in the provision of product development services. The firm offers varied products and dosage forms across therapeutic categories, which includes gastroenterology, hypertension, dermatology, nephrology, respiratory, virology, diabetes, wound care, anti-infectives, pharmacovigilance and nicotine replacement therapy (NRT). Its offers lozenges, which includes center-filled, soft-centered lozenges, center-filled, powder lozenges, herbal lozenges, and medicated lozenges. Its APIs products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Diclofenac Potassium, Nifedipine, Atenolol, Cilnidipine, and Ciprofloxacin HCl. The firm also owns Razel (Rousvastatin) franchise for the India and Nepal.
Equity review factors
Factor profile
Factor scores are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags and screen results for JB Chemicals & Pharmaceuticals Ltd are part of the Wright portfolio review.
Run your free portfolio reviewFundamental snapshot
Fundamentals at a glance
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.